Gen. H. Norman Schwarzkopf to Accept Wistar Institute President's Award

Gen. H. Norman Schwarzkopf to Accept Wistar Institute President's Award

May 1, 2005

(PHILADELPHIA - May 2, 2005) - Retired Gen. H. Norman Schwarzkopf will accept the second annual Wistar Institute President's Award on Wednesday, May 4, at a luncheon at The Wistar Institute. The award honors a public figure who has not only confronted cancer but also served as an advocate for improvements in cancer education and research. Gen. Schwarzkopf, a prostate cancer survivor, is being honored for his cancer advocacy efforts.

Gen. Schwarzkopf is perhaps best known for his service as Commander in Chief, United States Central Command, and Commander of Operations Desert Shield and Desert Storm. In the latter capacity, he coordinated the efforts of all Allied forces from Riyadh, Saudi Arabia, from August 1990, soon after Iraq invaded Kuwait, until August 1991, when he retired from military service.

In March 1994, Gen. Schwarzkopf was diagnosed with prostate cancer and his prostate was removed. Since then, he has become a national spokesperson for prostate cancer awareness. One of his key messages has been the importance of overcoming the attitudes of avoidance and denial that many men have about prostate health.

According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, second only to skin cancer. The society estimates that there will be about 232,090 new cases of prostate cancer in the United States in 2005. About 30,350 men will die of this disease. Prostate cancer is the second leading cause of cancer death in men, behind lung cancer. While 1 man in 6 will get prostate cancer during his lifetime, only 1 man in 33 will die of this disease. The death rate for prostate cancer is going down. And the disease is being found earlier as well.

In addition to Gen. Schwarzkopf, speakers at the awards luncheon will include Russel E. Kaufman, M.D., president and CEO of The Wistar Institute, and Brian H. Dovey, chair of Wistar's Board of Managers and a general partner of Domain Associates, a venture capital firm with an exclusive focus on the life sciences.

In welcome to Gen. Schwarzkopf, cadets from the Valley Forge Military Academy will form an honor guard at the main entrance to The Wistar Institute, remaining in place between 11:30 a.m. and 12:30 p.m. (Gen. Schwarzkopf is an alumnus of the Academy.) Additionally, Gen. Schwarzkopf will be presented with a monogrammed white laboratory coat by Dr. Kaufman, M.D., following his acceptance at about 1:45 p.m. of the Wistar Institute President's Award. He will then tour the laboratory of David W. Speicher, Ph.D., a Wistar researcher using the new technologies of proteomics to develop blood tests for early detection of lung cancer and other top cancer killers.

The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the causes and cures for major diseases, including cancer, cardiovascular disease, autoimmune disorders, and infectious diseases. Founded in 1892 as the first institution of its kind in the nation, The Wistar Institute today is a National Cancer Institute-designated Cancer Center focused on basic and translational research. Discoveries at Wistar have led to the development of vaccines for such diseases as rabies and rubella, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools. News releases from The Wistar Institute are available to reporters by direct e-mail upon request.